File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1067/mpd.2001.115572
- Scopus: eid_2-s2.0-0034969414
- PMID: 11445812
- WOS: WOS:000169877100033
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Octreotide for treatment of postoperative chylothorax
Title | Octreotide for treatment of postoperative chylothorax |
---|---|
Authors | |
Issue Date | 2001 |
Publisher | Mosby, Inc. The Journal's web site is located at http://www.elsevier.com/locate/jpeds |
Citation | Journal Of Pediatrics, 2001, v. 139 n. 1, p. 157-159 How to Cite? |
Abstract | Two infants who developed chylothorax after surgery for congenital heart disease were treated successfully with subcutaneous octreotide. Apart from reducing chyle output, octreotide decreased the triglyceride content of the pleural fluid. |
Persistent Identifier | http://hdl.handle.net/10722/170310 |
ISSN | 2023 Impact Factor: 3.9 2023 SCImago Journal Rankings: 1.043 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cheung, YF | en_US |
dc.contributor.author | Leung, MP | en_US |
dc.contributor.author | Yip, MM | en_US |
dc.date.accessioned | 2012-10-30T06:07:24Z | - |
dc.date.available | 2012-10-30T06:07:24Z | - |
dc.date.issued | 2001 | en_US |
dc.identifier.citation | Journal Of Pediatrics, 2001, v. 139 n. 1, p. 157-159 | en_US |
dc.identifier.issn | 0022-3476 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/170310 | - |
dc.description.abstract | Two infants who developed chylothorax after surgery for congenital heart disease were treated successfully with subcutaneous octreotide. Apart from reducing chyle output, octreotide decreased the triglyceride content of the pleural fluid. | en_US |
dc.language | eng | en_US |
dc.publisher | Mosby, Inc. The Journal's web site is located at http://www.elsevier.com/locate/jpeds | en_US |
dc.relation.ispartof | Journal of Pediatrics | en_US |
dc.subject.mesh | Chylothorax - Drug Therapy | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Heart Defects, Congenital - Surgery | en_US |
dc.subject.mesh | Hormones - Administration & Dosage - Therapeutic Use | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Infant | en_US |
dc.subject.mesh | Injections, Subcutaneous | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Octreotide - Administration & Dosage - Therapeutic Use | en_US |
dc.subject.mesh | Pleural Effusion - Metabolism | en_US |
dc.subject.mesh | Postoperative Complications - Drug Therapy | en_US |
dc.title | Octreotide for treatment of postoperative chylothorax | en_US |
dc.type | Article | en_US |
dc.identifier.email | Cheung, YF:xfcheung@hku.hk | en_US |
dc.identifier.authority | Cheung, YF=rp00382 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1067/mpd.2001.115572 | en_US |
dc.identifier.pmid | 11445812 | - |
dc.identifier.scopus | eid_2-s2.0-0034969414 | en_US |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-0034969414&selection=ref&src=s&origin=recordpage | en_US |
dc.identifier.volume | 139 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.spage | 157 | en_US |
dc.identifier.epage | 159 | en_US |
dc.identifier.isi | WOS:000169877100033 | - |
dc.publisher.place | United States | en_US |
dc.identifier.scopusauthorid | Cheung, YF=7202111067 | en_US |
dc.identifier.scopusauthorid | Leung, MP=7201944800 | en_US |
dc.identifier.scopusauthorid | Yip, MM=15746101200 | en_US |
dc.identifier.issnl | 0022-3476 | - |